endpoints.news is our new home on June 1. endpts.com will still work, but the front door is now https://endpoints.news

Pharma channel feed

New year, new hire: Mod­er­na taps Mer­ck vet­er­an as lat­est com­mer­cial ex­ec

3 years ago
Marketing

TG's MS hope­ful ubli­tux­imab not cost-ef­fec­tive at Ocre­vus' price, ICER says in ev­i­dence re­port

3 years ago

Cor­rect­ed: Fac­ing decades in prison, two biotech lead­ers charged with wire and se­cu­ri­ties fraud, ly­ing to in­ves­ti­ga­tors

3 years ago
FDA+
Law

Up­dat­ed: Sev­er­al man­u­fac­tur­ers re­port Tam­i­flu short­age as flu sea­son reach­es high point

3 years ago
Manufacturing

Ahead of lecanemab de­ci­sion, Alzheimer's groups pe­ti­tion CMS to re­verse cov­er­age pol­i­cy

3 years ago

Re­al Chem­istry's hol­i­day gift to clients: fight­ing hate speech

3 years ago
Marketing

Om­nibus spend­ing bill fea­tures fund­ing to bol­ster the sup­ply chain and site in­spec­tions

3 years ago
FDA+
Manufacturing

Trends for 2023: What's com­ing next in phar­ma mar­ket­ing and drug com­mer­cial­iza­tion?

3 years ago
Marketing

Boehringer In­gel­heim deep­ens its col­lab­o­ra­tion with Click Ther­a­peu­tics in a deal worth $460M

3 years ago
Deals

No­var­tis to cut 280+ jobs in New Jer­sey

3 years ago

EC ap­proves first al­lo­gene­ic T cell ther­a­py for rare post-trans­plant com­pli­ca­tion

3 years ago

FDA re­ports short­ages for two of Eli Lil­ly's di­a­betes drugs will ex­tend in­to next year

3 years ago
FDA+
Manufacturing

Ab­b­Vie adds de­pres­sion in­di­ca­tion to Vray­lar's la­bel months af­ter Gon­za­lez touts $4B+ peak sales po­ten­tial

3 years ago
FDA+

Genen­tech and Bio­gen pen roy­al­ty deal for blood can­cer drug with big po­ten­tial

3 years ago

Q&A: Ire­land bio­phar­ma leader dis­cuss­es the na­tion’s 2022 boost in man­u­fac­tur­ing

3 years ago
Manufacturing

Black­stone re­con­sid­ers fu­ture of Japan­ese phar­ma — re­port

3 years ago
Deals

US-list­ed Chi­nese biotechs dodge threat of delist­ing

3 years ago

As­traZeneca nabs 6 more months for Sym­bi­cort patent in lat­est court rul­ing

3 years ago
Law

De­spite 'lack­lus­ter' 2022, PwC re­mains 'bull­ish' on phar­ma M&A in 2023

3 years ago
Deals

Ab­b­Vie opts out of in­dus­try trade groups PhRMA, BIO plus Busi­ness Round­table

3 years ago

Up­dat­ed: FDA punts PDU­FA date for an­oth­er in­di­ca­tion for As­traZeneca, Mer­ck­'s can­cer drug Lyn­parza

3 years ago
FDA+

Mer­ck marks 1M Minecraft down­loads in gam­ing-meets-sci­ence ed­u­ca­tion ef­fort

3 years ago
Marketing

US set to pay near­ly $2B for Pfiz­er's Covid-19 treat­ment Paxlovid in 2023

3 years ago

Catal­ent to build a $40M an­a­lyt­i­cal ser­vices fa­cil­i­ty in North Car­oli­na's Re­search Tri­an­gle

3 years ago
Manufacturing
First page Previous page 153154155156157158159 Next page Last page
A service from the Financial Times